The prognostic and biology of tumour-infiltrating lymphocytes in the immunotherapy of cancer
{{output}}
Tumour immunotherapy has achieved remarkable clinical success in many different types of cancer in the past two decades. The outcome of immune checkpoint inhibitors in cancer patients has been linked to the quality and magnitude of T cell, NK cell, and more re... ...
